271 related articles for article (PubMed ID: 28033448)
1. Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and Consequences.
Kurian AW; Friese CR; Bondarenko I; Jagsi R; Li Y; Hamilton AS; Ward KC; Katz SJ
JAMA Oncol; 2017 Mar; 3(3):391-397. PubMed ID: 28033448
[TBL] [Abstract][Full Text] [Related]
2. Oncologists' influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
Katz SJ; Hawley ST; Bondarenko I; Jagsi R; Ward KC; Hofer TP; Kurian AW
Breast Cancer Res Treat; 2017 Oct; 165(3):751-756. PubMed ID: 28689364
[TBL] [Abstract][Full Text] [Related]
3. Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer.
Katz SJ; Janz NK; Abrahamse P; Wallner LP; Hawley ST; An LC; Ward KC; Hamilton AS; Morrow M; Jagsi R
JAMA Surg; 2017 Jul; 152(7):658-664. PubMed ID: 28384687
[TBL] [Abstract][Full Text] [Related]
4. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
[TBL] [Abstract][Full Text] [Related]
5. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
[TBL] [Abstract][Full Text] [Related]
6. Recent Trends in Chemotherapy Use and Oncologists' Treatment Recommendations for Early-Stage Breast Cancer.
Kurian AW; Bondarenko I; Jagsi R; Friese CR; McLeod MC; Hawley ST; Hamilton AS; Ward KC; Hofer TP; Katz SJ
J Natl Cancer Inst; 2018 May; 110(5):493-500. PubMed ID: 29237009
[TBL] [Abstract][Full Text] [Related]
7. Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer.
Kurian AW; Ward KC; Abrahamse P; Hamilton AS; Deapen D; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2020 Apr; 6(4):e196400. PubMed ID: 32027353
[TBL] [Abstract][Full Text] [Related]
8. Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.
Katz SJ; Bondarenko I; Ward KC; Hamilton AS; Morrow M; Kurian AW; Hofer TP
JAMA Surg; 2018 Oct; 153(10):909-916. PubMed ID: 29971344
[TBL] [Abstract][Full Text] [Related]
9. Residual treatment disparities after oncology referral for rectal cancer.
Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
[TBL] [Abstract][Full Text] [Related]
10. The influence of non-clinical patient factors on medical oncologists' decisions to recommend breast cancer adjuvant chemotherapy.
Pini TM; Hawley ST; Li Y; Katz SJ; Griggs JJ
Breast Cancer Res Treat; 2012 Jul; 134(2):867-74. PubMed ID: 22718307
[TBL] [Abstract][Full Text] [Related]
11. Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011.
Wilson LE; Pollack CE; Greiner MA; Dinan MA
Breast Cancer Res Treat; 2018 Jul; 170(2):361-371. PubMed ID: 29536319
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy decisions and patient experience with the recurrence score assay for early-stage breast cancer.
Friese CR; Li Y; Bondarenko I; Hofer TP; Ward KC; Hamilton AS; Deapen D; Kurian AW; Katz SJ
Cancer; 2017 Jan; 123(1):43-51. PubMed ID: 27775837
[TBL] [Abstract][Full Text] [Related]
13. Access to breast reconstruction after mastectomy and patient perspectives on reconstruction decision making.
Morrow M; Li Y; Alderman AK; Jagsi R; Hamilton AS; Graff JJ; Hawley ST; Katz SJ
JAMA Surg; 2014 Oct; 149(10):1015-21. PubMed ID: 25141939
[TBL] [Abstract][Full Text] [Related]
14. Treatment experiences of Latinas after diagnosis of breast cancer.
Katz SJ; Wallner LP; Abrahamse PH; Janz NK; Martinez KA; Shumway DA; Hamilton AS; Ward KC; Resnicow KA; Hawley ST
Cancer; 2017 Aug; 123(16):3022-3030. PubMed ID: 28398629
[TBL] [Abstract][Full Text] [Related]
15. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
[TBL] [Abstract][Full Text] [Related]
16. Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Kurian AW; Ward KC; Hamilton AS; Deapen DM; Abrahamse P; Bondarenko I; Li Y; Hawley ST; Morrow M; Jagsi R; Katz SJ
JAMA Oncol; 2018 Aug; 4(8):1066-1072. PubMed ID: 29801090
[TBL] [Abstract][Full Text] [Related]
17. Primary care provider-reported involvement in breast cancer treatment decisions.
Wallner LP; Li Y; McLeod MC; Gargaro J; Kurian AW; Jagsi R; Radhakrishnan A; Hamilton AS; Ward KC; Hawley ST; Katz SJ
Cancer; 2019 Jun; 125(11):1815-1822. PubMed ID: 30707773
[TBL] [Abstract][Full Text] [Related]
18. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract][Full Text] [Related]
19. Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Kurian AW; Li Y; Hamilton AS; Ward KC; Hawley ST; Morrow M; McLeod MC; Jagsi R; Katz SJ
J Clin Oncol; 2017 Jul; 35(20):2232-2239. PubMed ID: 28402748
[TBL] [Abstract][Full Text] [Related]
20. Satisfaction with surgery outcomes and the decision process in a population-based sample of women with breast cancer.
Lantz PM; Janz NK; Fagerlin A; Schwartz K; Liu L; Lakhani I; Salem B; Katz SJ
Health Serv Res; 2005 Jun; 40(3):745-67. PubMed ID: 15960689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
